Effectiveness of Monovalent mRNA Vaccines Against COVID-19âAssociated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States â IVY Network, 18 States, December 26, 2021âAugust 31, 2022 | MMWR - discu.eu

Reddit

3- dose monovalent mRNA VE against COVID hospitalization decreased with time. 3 -dose VE during the BA.1/BA.2 & BA.4/BA.5 periods was 79% & 60%, respectively, during initial 120 days after 3rd dose & decreased to 41% & 29%, respectively, after 120 days. https://www.cdc.gov/mmwr/volumes/71/wr/mm7142a3.htm 2 comments 22/10/2022 science

CDC review finds that 120 days after three doses of the original monovalent vaccines, protection against hospitalization and death decreased to 41% and 29%, respectively. https://www.cdc.gov/mmwr/volumes/71/wr/mm7142a3.htm 50 comments 21/10/2022 science

Linking pages

COVID Science Is Moving Backwards - The Atlantic https://www.theatlantic.com/science/archive/2022/12/covid-science-data-bivalent-vaccines-paxlovid/672378/ 5 comments

Related searches:

Search whole site: site:www.cdc.gov

Search title: Effectiveness of Monovalent mRNA Vaccines Against COVID-19âAssociated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States â IVY Network, 18 States, December 26, 2021âAugust 31, 2022 | MMWR

See how to search.

Submit link to: